CENTAURUS FINANCIAL, INC. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
CENTAURUS FINANCIAL, INC. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$834,000
-14.0%
25,065
+0.3%
0.07%
-14.6%
Q2 2021$970,000
-22.6%
25,000
-3.8%
0.08%
-33.9%
Q1 2021$1,253,000
-7.4%
26,0000.0%0.12%
-12.7%
Q4 2020$1,353,000
+94.4%
26,0000.0%0.14%
+47.9%
Q3 2020$696,000
+78.5%
26,000
+30.0%
0.10%
+65.5%
Q2 2020$390,000
+163.5%
20,000
+33.3%
0.06%
+93.3%
Q1 2020$148,000
+33.3%
15,000
+50.0%
0.03%
+87.5%
Q4 2019$111,000
+98.2%
10,0000.0%0.02%
+77.8%
Q3 2019$56,000
-35.6%
10,0000.0%0.01%
-35.7%
Q2 2019$87,000
-99.1%
10,000
+12400.0%
0.01%
-76.3%
Q1 2019$10,000,000800.06%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders